ClinicalTrials.Veeva

Find clinical trials for Prostate Cancer in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Aurora, CO, USA:

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Biological: aglatimagene besadenovec

Phase 2

Candel Therapeutics

Golden, Colorado, United States and 22 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Denver, Colorado, United States and 131 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...

Active, not recruiting
Prostate Cancer
Biological: Aglatimagene besadenovec + valacyclovir
Biological: Placebo + valacyclovir

Phase 3

Candel Therapeutics

Parker, Colorado, United States and 72 other locations

enzalutamide or abiraterone/prednisone alone in asymptomatic or mildly symptomatic subjects with progressive, metastatic castration-resistant prostate...

Active, not recruiting
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Drug: Tazemetostat
Drug: Abiraterone/prednisone

Phase 1, Phase 2

Epizyme

Denver, Colorado, United States of America and 23 other locations

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC and SGC.

Active, not recruiting
Prostatic Disease
Salivary Gland Cancer
Drug: Rimiducid
Biological: P-PSMA-101 CAR-T cells

Phase 1

Poseida Therapeutics

Denver, Colorado, United States and 9 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Abiraterone Acetate
Drug: Placebo

Phase 2, Phase 3

Lilly
Lilly

Lone Tree, Colorado, United States and 105 other locations

patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Prostate Cancer Metastatic
Drug: HC-1119
Drug: Enzalutamide

Phase 3

Hinova Pharmaceuticals

Denver, Colorado, United States and 57 other locations

therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: Enzalutamide 160 mg
Drug: Olaparib 400 mg

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Aurora, Colorado, United States and 32 other locations

period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Non-Metastatic Castration-Resistant Prostate Cancer
Drug: Abiraterone
Drug: Methylprednisolone

Phase 1

Myovant Sciences

Lakewood, Colorado, United States and 16 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Aurora, Colorado, United States and 220 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems